Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions
Article first published online: 18 JUL 2006
Copyright © 1989 Wiley-Liss, Inc., A Wiley Company
International Journal of Cancer
Volume 44, Issue 1, pages 63–66, 15 July 1989
How to Cite
Aozasa, K., Ohsawa, M., Tajima, K., Sasaki, R., Maeda, H., Matsunaga, T. and Friedmann, I. (1989), Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int. J. Cancer, 44: 63–66. doi: 10.1002/ijc.2910440112
- Issue published online: 18 JUL 2006
- Article first published online: 18 JUL 2006
- Manuscript Received: 6 FEB 1989
- Cancer Research from the Ministry of Health and Welfare
- Foundation for Promotion of Cancer Research
- Travel Grant from the Princess Takamatsu Cancer Research Fund, Japan
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.